TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

SOLVONIS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

SOLVONIS

ST13

US500000079422293

Classe

1, 5, 42, 44

Pedido

79422293

Registro

8140050

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

24

Atualização mais recente

18/05/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 42, 44

Data de depósito

06/12/2024

Data de registro

17/02/2026

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

17/02/2026

Última transação

18/05/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

84

Localização do titular

GB

Examinador

BLAZICH, JOAN MICHELE

Unidade examinadora

N40

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Solvonis Therapeutics plc
Graft Polymer (UK) Plc

Representantes

William C. Wright Epstein Drangel LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemicals and chemical substances for use in industry, in science and chemical preparations for use in the manufacture of pharmaceuticals; biological and biochemical substances being organic chemical compounds, synthetic chemical compounds, enzymes, nucleic acids, non-medical chemical reagents, biochemical catalysts and non-medical diagnostic reagents for use in industry and science, peptide substrates for scientific purposes, proteins for use in manufacture, chemical solvents for use in the manufacture of pharmaceuticals, and small molecule chemical compounds and chemical intermediates for use in the manufacture of pharmaceuticals

Classe 5

Pharmaceuticals and medical preparations being chemical intermediates, being chemical diagnostic preparations for medical purposes and being chemical preparations, small molecule pharmaceutical preparations and organic and synthetic pharmaceutical compounds for the treatment of neurodegenerative diseases, movement disorders, neurodevelopmental disorders, neurological disorders, conditions and diseases and of central nervous system disorders, conditions and diseases; pharmaceuticals and medical preparations being chemical preparations and small molecule pharmaceutical preparations and organic and synthetic pharmaceutical compounds for the treatment of behavioural health disorders, mental health disorders and addiction

Classe 42

Scientific laboratory services; clinical research services, namely, conducting clinical trials for others; scientific advisory, scientific analysis, assessment being quality control for others, assistance being technical support for others being testing and evaluation of clinical, laboratory and medical equipment and software to improve performance and efficiency of such equipment and software, and troubleshooting in the nature of diagnosing problems with clinical, laboratory and medical equipment and software, auditing being quality control for others, consultancy, design, development, due diligence being quality control for others, quality evaluation, scientific information, inspection being quality control for others, research and testing services in the fields of chemicals, of chemical substances, of biological substances, of biochemical substances, of science, of clinical research, of artificial intelligence, of machine learning and of biotechnology; scientific analysis, assessment being quality control for others, assistance being technical support for others being testing and evaluation of clinical, laboratory and medical equipment and software to improve performance and efficiency of such equipment and software, and troubleshooting in the nature of diagnosing problems with clinical, laboratory and medical equipment and software, auditing being quality control for others, design, development, due diligence being quality control for others, quality evaluation, inspection being quality control for others, research and testing services in the fields of medicine, of pharmaceuticals, of medical diagnostics, of biomarkers and of bioinformatics; auditing being quality control for others, design, development, due diligence being quality control for others, inspection being quality control for others and research services in the fields of chemicals, chemical substances, biological substances, biochemical substances and pharmaceuticals for therapy, of telehealth, of mental health, of medical counselling, of psychology, of psychotherapy, of health counselling, of behavioural health counselling, of behavioural health, of behaviour and of addiction

Classe 44

Medical services; pharmaceutical compounding services; cognitive, behavioural, central nervous system, neurological, physical, psycho-social and mental health therapy services; cognitive, behavioural, central nervous system, neurological, physical, psycho-social and mental health telehealth services; mental health services; medical counselling services; psychological counselling services; psychotherapy services; health counselling services; behavioural health counselling services; health care services, namely design and provision of behavioural health treatment programmes; health care services, namely addiction counselling and treatment services; medical services, namely administration, advisory, analysis, assessment, assistance, consultancy, evaluation, information and testing services in the fields of cognitive, behavioural, central nervous system, neurological, physical, psycho-social and mental health therapy, of telehealth, of mental health, of medical counselling, of psychology, of psychotherapy, of health counselling, of behavioural health counselling, of behavioural health, of behaviour and of addiction; medical advisory, consultancy and information services in the fields of medicine, of pharmaceuticals, of medical diagnostics, of biomarkers and of bioinformatics

Publicações

Histórico de despachos e eventos da marca no USPTO.

24 publicações encontradas

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

17/05/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

17/02/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

17/02/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

30/12/2025

PUBO

PUBLISHED FOR OPPOSITION

30/12/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

24/12/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/12/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

03/12/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/12/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

03/12/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/12/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

16/11/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

16/11/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

16/11/2025

RFNT

REFUSAL PROCESSED BY IB

16/08/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

26/07/2025

RFRR

REFUSAL PROCESSED BY MPU

26/07/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/06/2025

CNRT

NON-FINAL ACTION WRITTEN

02/06/2025

DOCK

ASSIGNED TO EXAMINER

27/05/2025

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

16/05/2025

MAFR

APPLICATION FILING RECEIPT MAILED

25/04/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

25/04/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

24/04/2025

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace SOLVONIS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.